These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 11049992)

  • 41. Immunoglobulin class and subclass deficiencies prior to Epstein-Barr virus infection in males with X-linked lymphoproliferative disease.
    Grierson HL; Skare J; Hawk J; Pauza M; Purtilo DT
    Am J Med Genet; 1991 Sep; 40(3):294-7. PubMed ID: 1683154
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The abnormal gene in X-linked lymphoproliferative syndrome.
    Sullivan JL
    Curr Opin Immunol; 1999 Aug; 11(4):431-4. PubMed ID: 10448142
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Skin lesions in a boy with X-linked lymphoproliferative disorder: comparison of 5 SH2D1A deletion cases.
    Mejstríková E; Janda A; Hrusák O; Bucková H; Vlcková M; Hancárová M; Freiberger T; Ravcuková B; Vesely K; Fajkusová L; Kopecková L; Sumerauer D; Kabícková E; Sedivá A; Stary J; Sedlácek Z
    Pediatrics; 2012 Feb; 129(2):e523-8. PubMed ID: 22271700
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Study of SH2D1A gene mutation in paediatric patients with B-cell lymphoma.
    Koochakzadeh L; Hosseinverdi S; Hedayat M; Farahani F; Tofighi A; Eghbali M; Bidoki AZ; Izadyar M; Rahiminejad MS; Ramyar A; Aghamohammadi A; Rezaei N
    Allergol Immunopathol (Madr); 2015; 43(6):568-70. PubMed ID: 25982576
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Frequent mutations in SH2D1A (XLP) in males presenting with high-grade mature B-cell neoplasms.
    Sandlund JT; Shurtleff SA; Onciu M; Horwitz E; Leung W; Howard V; Rencher R; Conley ME
    Pediatr Blood Cancer; 2013 Sep; 60(9):E85-7. PubMed ID: 23589280
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cellular and molecular pathogenesis of X-linked lymphoproliferative disease.
    Moretta A; Bottino C; Parolini S; Moretta L; Biassoni R; Notarangelo LD
    Curr Opin Allergy Clin Immunol; 2001 Dec; 1(6):513-7. PubMed ID: 11964734
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Lymphocytic vasculitis in X-linked lymphoproliferative disease.
    Dutz JP; Benoit L; Wang X; Demetrick DJ; Junker A; de Sa D; Tan R
    Blood; 2001 Jan; 97(1):95-100. PubMed ID: 11133747
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A yeast artificial chromosome (YAC) contig encompassing the critical region of the X-linked lymphoproliferative disease (XLP) locus.
    Lanyi A; Li B; Li S; Talmadge CB; Brichacek B; Davis JR; Kozel BA; Trask B; van den Engh G; Uzvolgyi E; Stanbridge EJ; Nelson DL; Chinault C; Heslop H; Gross TG; Seemayer TA; Klein G; Purtilo DT; Sumegi J
    Genomics; 1997 Jan; 39(1):55-65. PubMed ID: 9027486
    [TBL] [Abstract][Full Text] [Related]  

  • 49. No mutations of SAP/SH2D1A/DSHP and perforin genes in patients with Epstein-Barr virus-associated hemophagocytic syndrome in Japan.
    Ma X; Okamura A; Yosioka M; Ishiguro N; Kikuta H; Kobayashi K
    J Med Virol; 2001 Oct; 65(2):358-61. PubMed ID: 11536244
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Epstein-Barr virus LMP1 inhibits the expression of SAP gene and upregulates Th1 cytokines in the pathogenesis of hemophagocytic syndrome.
    Chuang HC; Lay JD; Hsieh WC; Wang HC; Chang Y; Chuang SE; Su IJ
    Blood; 2005 Nov; 106(9):3090-6. PubMed ID: 16002423
    [TBL] [Abstract][Full Text] [Related]  

  • 51. SH2D1A expression in Burkitt lymphoma cells is restricted to EBV positive group I lines and is downregulated in parallel with immunoblastic transformation.
    Nagy N; Maeda A; Bandobashi K; Kis LL; Nishikawa J; Trivedi P; Faggioni A; Klein G; Klein E
    Int J Cancer; 2002 Aug; 100(4):433-40. PubMed ID: 12115526
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Early and rapid detection of X-linked lymphoproliferative syndrome with SH2D1A mutations by flow cytometry.
    Zhao M; Kanegane H; Kobayashi C; Nakazawa Y; Ishii E; Kasai M; Terui K; Gocho Y; Imai K; Kiyasu J; Nonoyama S; Miyawaki T
    Cytometry B Clin Cytom; 2011 Jan; 80(1):8-13. PubMed ID: 20632414
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Evaluation of families wherein a single male manifests a phenotype of X-linked lymphoproliferative disease (XLP).
    Grierson HL; Skare J; Church J; Silberman T; Davis JR; Kobrinsky N; McGregor R; Israels S; McCarty J; Andrews LG
    Am J Med Genet; 1993 Sep; 47(4):458-63. PubMed ID: 8256804
    [TBL] [Abstract][Full Text] [Related]  

  • 54. X-linked lymphoproliferative syndrome in mainland China: review of clinical, genetic, and immunological characteristic.
    Xu T; Zhao Q; Li W; Chen X; Xue X; Chen Z; Du X; Bai X; Zhao Q; Zhou L; Tang X; Yang X; Kanegane H; Zhao X
    Eur J Pediatr; 2020 Feb; 179(2):327-338. PubMed ID: 31754776
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Diagnosis of X-linked lymphoproliferative disease by analysis of SLAM-associated protein expression.
    Gilmour KC; Cranston T; Jones A; Davies EG; Goldblatt D; Thrasher A; Kinnon C; Nichols KE; Gaspar HB
    Eur J Immunol; 2000 Jun; 30(6):1691-7. PubMed ID: 10898506
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The apoptosis modulating role of SAP (SLAM associated protein) contributes to the symptomatology of the X linked lymphoproliferative disease.
    Nagy N; Matskova L; Hellman U; Klein G; Klein E
    Cell Cycle; 2009 Oct; 8(19):3086-90. PubMed ID: 19738428
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Expression of SH2D1A in five classical Hodgkin's disease-derived cell lines.
    Kis LL; Nagy N; Klein G; Klein E
    Int J Cancer; 2003 May; 104(5):658-61. PubMed ID: 12594824
    [TBL] [Abstract][Full Text] [Related]  

  • 58. XLP: clinical features and molecular etiology due to mutations in SH2D1A encoding SAP.
    Tangye SG
    J Clin Immunol; 2014 Oct; 34(7):772-9. PubMed ID: 25085526
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Association of the X-linked lymphoproliferative disease gene product SAP/SH2D1A with 2B4, a natural killer cell-activating molecule, is dependent on phosphoinositide 3-kinase.
    Aoukaty A; Tan R
    J Biol Chem; 2002 Apr; 277(15):13331-7. PubMed ID: 11815622
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clinical similarities and differences of patients with X-linked lymphoproliferative syndrome type 1 (XLP-1/SAP deficiency) versus type 2 (XLP-2/XIAP deficiency).
    Pachlopnik Schmid J; Canioni D; Moshous D; Touzot F; Mahlaoui N; Hauck F; Kanegane H; Lopez-Granados E; Mejstrikova E; Pellier I; Galicier L; Galambrun C; Barlogis V; Bordigoni P; Fourmaintraux A; Hamidou M; Dabadie A; Le Deist F; Haerynck F; Ouachée-Chardin M; Rohrlich P; Stephan JL; Lenoir C; Rigaud S; Lambert N; Milili M; Schiff C; Chapel H; Picard C; de Saint Basile G; Blanche S; Fischer A; Latour S
    Blood; 2011 Feb; 117(5):1522-9. PubMed ID: 21119115
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.